GRM1 RNA-Seq from TCGA for Alpha–radiopharmaceutical 211At-AITM reduces mGluR1 and induces senescence to elicit long-lasting antitumor efficacy

Published: 26 January 2023| Version 2 | DOI: 10.17632/xfh84npb2h.2
Contributor:
Lin Xie

Description

GRM1 RNA-Seq from TCGA

Files

Steps to reproduce

All available GRM1 mRNA data as of March 2022 were downloaded from cBioPortal (www.cbioportal.org/), and raw sequencing data from TCGA were imported (https://cancergenome.nih.gov/). Patient samples covered 10,967 across 32 tumor types.

Institutions

Kokuritsu Kenkyu Kaihatsu Hojin Ryoshi Kagaku Gijutsu Kenkyu Kaihatsu Kiko

Categories

Radiopharmaceutical, Targeted Radionuclide Therapy, Metabotropic Glutamate Receptor Antagonist

License